Revisiting secondary prevention in coronary heart disease
Secondary prevention in coronary heart disease is the prevention of occurrence of recurrent coronary events after clinical diagnosis. High level of adherence to secondary prevention interventions, especially aggressive lifestyle changes and pharmacotherapy can lead to significant decline in recurren...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-11-01
|
| Series: | Indian Heart Journal |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0019483222003777 |
| _version_ | 1811291823125037056 |
|---|---|
| author | Alben Sigamani Rajeev Gupta |
| author_facet | Alben Sigamani Rajeev Gupta |
| author_sort | Alben Sigamani |
| collection | DOAJ |
| description | Secondary prevention in coronary heart disease is the prevention of occurrence of recurrent coronary events after clinical diagnosis. High level of adherence to secondary prevention interventions, especially aggressive lifestyle changes and pharmacotherapy can lead to significant decline in recurrent coronary events. Both international and Indian studies have reported low adherence to such therapies. Evidence-based useful interventions include regular physical activity, yoga, intake of healthy diet, smoking and tobacco use cessation and weight management. Pharmacotherapeutic interventions useful are anti-platelet therapy, target oriented lipid lowering therapy with statins, beta blockers and angiotensin converting enzyme inhibitors in patients with impaired left ventricular function. Hypertension and diabetes management with control to targets is important. Novel strategies include use of anticoagulants, anti-inflammatory drugs, and triglyceride lowering for residual risk. Physician and patient level interventions using multifaceted educational, socioeconomic and technological innovations are important to promote life-long adherence to these strategies. |
| first_indexed | 2024-04-13T04:35:54Z |
| format | Article |
| id | doaj.art-7b6d93c5c7594bbe97f5ec977a2fba5a |
| institution | Directory Open Access Journal |
| issn | 0019-4832 |
| language | English |
| last_indexed | 2024-04-13T04:35:54Z |
| publishDate | 2022-11-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Indian Heart Journal |
| spelling | doaj.art-7b6d93c5c7594bbe97f5ec977a2fba5a2022-12-22T03:02:10ZengElsevierIndian Heart Journal0019-48322022-11-01746431440Revisiting secondary prevention in coronary heart diseaseAlben Sigamani0Rajeev Gupta1Numen Health, Bengaluru, Karnataka, 560095, India; Corresponding author. Numen Health, Bengaluru, Karnataka, 560095, India.Department of Preventive Cardiology and Medicine, Eternal Heart Care Centre & Research Institute, Jaipur, Rajasthan, 302017, IndiaSecondary prevention in coronary heart disease is the prevention of occurrence of recurrent coronary events after clinical diagnosis. High level of adherence to secondary prevention interventions, especially aggressive lifestyle changes and pharmacotherapy can lead to significant decline in recurrent coronary events. Both international and Indian studies have reported low adherence to such therapies. Evidence-based useful interventions include regular physical activity, yoga, intake of healthy diet, smoking and tobacco use cessation and weight management. Pharmacotherapeutic interventions useful are anti-platelet therapy, target oriented lipid lowering therapy with statins, beta blockers and angiotensin converting enzyme inhibitors in patients with impaired left ventricular function. Hypertension and diabetes management with control to targets is important. Novel strategies include use of anticoagulants, anti-inflammatory drugs, and triglyceride lowering for residual risk. Physician and patient level interventions using multifaceted educational, socioeconomic and technological innovations are important to promote life-long adherence to these strategies.http://www.sciencedirect.com/science/article/pii/S0019483222003777Coronary heart diseaseSecondary preventionPharmacotherapyDigital health |
| spellingShingle | Alben Sigamani Rajeev Gupta Revisiting secondary prevention in coronary heart disease Indian Heart Journal Coronary heart disease Secondary prevention Pharmacotherapy Digital health |
| title | Revisiting secondary prevention in coronary heart disease |
| title_full | Revisiting secondary prevention in coronary heart disease |
| title_fullStr | Revisiting secondary prevention in coronary heart disease |
| title_full_unstemmed | Revisiting secondary prevention in coronary heart disease |
| title_short | Revisiting secondary prevention in coronary heart disease |
| title_sort | revisiting secondary prevention in coronary heart disease |
| topic | Coronary heart disease Secondary prevention Pharmacotherapy Digital health |
| url | http://www.sciencedirect.com/science/article/pii/S0019483222003777 |
| work_keys_str_mv | AT albensigamani revisitingsecondarypreventionincoronaryheartdisease AT rajeevgupta revisitingsecondarypreventionincoronaryheartdisease |